Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive ganaxolone in female children with PCDH19-related epilepsy
2018-004496-12Phase 3Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Apr 2019
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in PCDH19 clustering epilepsy (DEE9) and epilepsy comparing Ganaxolone adjunctive arm with Placebo adjunctive arm (2 arms). Started Apr 2019; status: completed.
02
Drugs
ganaxolone
03
Conditions
PCDH19 clustering epilepsy (DEE9)epilepsy
Beyond the preview
Go deeper on 2018-004496-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004496-12.